Artificial intelligence and visual inspection in cervical cancer screeningCarolyn Nakisige, Marlieke de Fouw, Johnblack Kabukye, Marat Sultanov, Naheed Nazrui, Aminur Rahman, Janine de Zeeuw, Jaap Koot, Arathi P Rao, Keerthana Prasad, Guruvare Shyamala, Premalatha Siddharta, Jelle Stekelenburg, Jogchum Jan Beltman
4 September 2023
European multidisciplinary tumor boards support cross-border networking and increase treatment options for patients with rare gynecological tumorsUlrika Joneborg, Alice Bergamini, Emelie Wallin, Giorgia Mangili, Olesya Solheim, Gloria Marquina, Antonio Casado, Erik Rokkones, John Coulter, Christianne A R Lok, Nienke van Trommel, Frédéric Amant, Pierre-Adrien Bolze, Jalid Sehouli, Sileny HanSee the full list of authors
2 October 2023
Pulmonary resection of residual lesions of pulmonary metastasis from gestational trophoblastic neoplasiaWeidi Wang, Yujia Kong, Yuan Li, Xirun Wan, Fengzhi Feng, Tong Ren, Jun Zhao, Yang Xiang, Junjun Yang
31 July 2023
Low-grade serous ovarian cancer: expert consensus report on the state of the scienceRachel N Grisham, Brian M Slomovitz, Nicole Andrews, Susana Banerjee, Jubilee Brown, Mark S Carey, Herman Chui, Robert L Coleman, Amanda N Fader, Stephanie Gaillard, Charlie Gourley, Anil K Sood, Bradley J Monk, Kathleen N Moore, Isabelle Ray-CoquardSee the full list of authors
17 August 2023
Identification of RAD51 foci in cancer-associated circulating cells of patients with high-grade serous ovarian cancer: association with treatment outcomesZena Alizzi, Sayeh Saravi, Saira Khalique, Thirza McDonald, Emmanouil Karteris, Marcia Hall
4 August 2023
Post-operative residual disease and number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinomaAnna Myriam Perrone, Camelia Alexandra Coada, Gloria Ravegnini, Antonio De Leo, Giuseppe Damiano, Eugenia De Crescenzo, Marco Tesei, Stella Di Costanzo, Lucia Genovesi, Daniela Rubino, Claudio Zamagni, Pierandrea De Iaco
10 July 2023
BRCA1/2 testing rates in epithelial ovarian cancer: a focus on the untested patientsLieke Lanjouw, Marian J E Mourits, Joost Bart, Arja ter Elst, Lieke P V Berger, Annemieke H van der Hout, Naufil Alam, Geertruida H de Bock
3 May 2023
Effect of actinomycin D on ovarian reserve in low-risk gestational trophoblastic neoplasiaWei Xue, Wei Cang, Jun Zhao, Fengzhi Feng, Xirun Wan, Tong Ren, Ling Qiu, Junjun Yang, Yang Xiang
8 June 2023
Prospective evaluation of an enhanced recovery after surgery (ERAS) pathway in a Norwegian cohort of patients with suspected or advanced ovarian cancerKristina Lindemann, Andreas Kleppe, Brynhildur Eyjólfsdóttir, Svana Heimisdottir Danbolt, Yun Yong Wang, Anne Gjertine Heli-Haugestøl, Sara L Walcott, Odd Mjåland, Gerd-Anita Navestad, Silje Hermanrud, Knut Erling Juul-Hansen, Ulf Kongsgaard
14 July 2023
Patient-reported nausea after implementation of an enhanced recovery after surgery protocol for gynae-oncology patientsKristina Lindemann, Svana Heimisdottir Danbolt, Lene Ramberg, Brynhildur Eyjólfsdóttir, Yun Yong Wang, Anne Gjertine Heli-Haugestøl, Sara L Walcott, Odd Mjåland, Gerd Anita Navestad, Silje Hermanrud, Knut Erling Juul-Hansen, Line K Bragstad, Randi Opheim, Andreas Kleppe, Ulf Kongsgaard
14 July 2023